Rajesh Bhudeti

Title: Innovations of Rajesh Bhudeti in Pharmaceutical Chemistry

Introduction

Rajesh Bhudeti is a notable inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative processes for the preparation of important compounds. With a total of three patents to his name, Bhudeti's work has the potential to impact the pharmaceutical industry positively.

Latest Patents

One of Rajesh Bhudeti's latest patents is titled "Process for the preparation of sucroferric oxyhydroxide." This invention relates to an improved process for producing pharmaceutical-grade sucroferric oxyhydroxide. The process results in a specific surface area of more than 16 m²/gm and demonstrates a phosphate binding capacity of at least 2.6 meq. of phosphate per 500 mg of iron, with a minimum of 0.2 mg P/mg of iron. Another significant patent is the "Method for the synthesis of ferric organic compounds." This invention provides an improved method for synthesizing Ferric Citrate and offers an amorphous form of Ferric Citrate with an active surface area of less than 14 sq.m/g.

Career Highlights

Rajesh Bhudeti is currently associated with Biophore India Pharmaceuticals Pvt. Ltd., where he continues to innovate and contribute to pharmaceutical research. His work focuses on enhancing the efficacy and safety of pharmaceutical compounds, which is crucial for patient care and treatment outcomes.

Collaborations

Rajesh has collaborated with several professionals in his field, including Jagadeesh Babu Rangisetty and Manik Reddy Pullagurla. These collaborations have likely enriched his research and contributed to the successful development of his patents.

Conclusion

In summary, Rajesh Bhudeti is a prominent inventor whose work in pharmaceutical chemistry has led to valuable innovations. His patents reflect a commitment to improving pharmaceutical processes and compounds, which can significantly benefit the industry and patients alike.